Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis Mathurin Fumery, Parambir S. Dulai, Samir Gupta, Larry J. Prokop, Sonia Ramamoorthy, William J. Sandborn, Siddharth Singh Clinical Gastroenterology and Hepatology Volume 15, Issue 5, Pages 665-674.e5 (May 2017) DOI: 10.1016/j.cgh.2016.11.025 Copyright © 2017 AGA Institute Terms and Conditions
Figure 1 Study selection flow sheet. Clinical Gastroenterology and Hepatology 2017 15, 665-674.e5DOI: (10.1016/j.cgh.2016.11.025) Copyright © 2017 AGA Institute Terms and Conditions
Figure 2 Pooled incidence rate (and 95% confidence interval) of progression to colorectal cancer in patients with ulcerative colitis with low-grade dysplasia. Clinical Gastroenterology and Hepatology 2017 15, 665-674.e5DOI: (10.1016/j.cgh.2016.11.025) Copyright © 2017 AGA Institute Terms and Conditions
Figure 3 Pooled incidence rate (and 95% confidence interval) of progression to advanced neoplasia (colorectal cancer or high-grade dysplasia) in patients with ulcerative colitis with low-grade dysplasia. Clinical Gastroenterology and Hepatology 2017 15, 665-674.e5DOI: (10.1016/j.cgh.2016.11.025) Copyright © 2017 AGA Institute Terms and Conditions